Peer review reports
From: Evaluation of tolerability with the co-formulation elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate for post-HIV exposure prophylaxis
| Original Submission |
| 21 Aug 2016 |
Submitted |
Original manuscript
|
|
Author responded |
Author comments
|
|
Reviewed |
Reviewer Report
|
| Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
|
Author responded |
Author comments
|
| Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
|
Author responded |
Author comments
|
| Resubmission - Version 4 |
|
Submitted |
Manuscript version 4
|
| Publishing |
| 22 Nov 2016 |
Editorially accepted |
|
| 29 Nov 2016 |
Article published |
10.1186/s12879-016-2056-3
|
Learn about peer review
